Tompkins Financial’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
Tompkins Financial's AMED Position: Q1 2021 in Review
Tompkins Financial held its Amedisys (AMED) position steady in Q1 2021 at 229 shares worth $61K. The position accounts for 0.01% of the portfolio, ranked #232.
Tompkins Financial first reported a position in AMED in Q2 2019 and has held it in 8 quarters since. The position peaked at $67K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.
- Tompkins Financial held 229 shares of Amedisys worth $61K as of Q1 2021.
- Tompkins Financial left its Amedisys share count unchanged in Q1 2021.
- Amedisys made up 0.01% of Tompkins Financial's portfolio in Q1 2021, its #232 holding.
- Tompkins Financial first reported a position in Amedisys in Q2 2019 and has held it in 8 quarters since.
- Tompkins Financial's Amedisys position peaked at $67K in Q4 2020.
- 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.
Based on Tompkins Financial's 13F filing for Q1 2021, filed 9 Jun 2021.